Skip to main content
S

SONOSCAPE MEDICAL CORP. — Investor Relations & Filings

Ticker · 300633 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2026-04-16 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300633

About SONOSCAPE MEDICAL CORP.

https://www.sonoscape.com

SonoScape Medical Corp. specializes in the research, development, and manufacturing of advanced medical diagnostic equipment. The company's primary product portfolio includes high-definition ultrasound systems, flexible endoscopy solutions, and electrocardiography devices. SonoScape focuses on delivering innovative imaging technology to healthcare providers globally, ranging from portable diagnostic tools to comprehensive trolley-based systems. Their ultrasound range covers various clinical applications such as cardiology, obstetrics, and radiology, while their endoscopy division provides high-resolution video processors and scopes for gastrointestinal and respiratory procedures. The company emphasizes continuous technological advancement and clinical efficiency to improve patient outcomes and diagnostic accuracy in diverse medical settings.

Recent filings

Filing Released Lang Actions
关于拟续聘会计师事务所的公告
Regulatory Filings Classification · 1% confidence The document is an announcement by Shenzhen Kaili Biomedical Technology Co., Ltd. regarding the proposed reappointment of its external auditor for the 2026 financial year. It outlines details of the audit firm, engagement procedures, and board/audit committee approvals, but does not itself present an audit report, financial statements, or dividend/meeting results. It is a regulatory announcement of a corporate action (auditor appointment) rather than a full annual or interim report, proxy statement, or actual audit report. It therefore falls into the fallback category for general regulatory filings.
2026-04-16 Chinese
2025年度独立董事述职报告（徐舜芝）
Governance Information Classification · 1% confidence The document is an annual performance report by the company’s independent director (独立董事述职报告), detailing governance activities, board attendance, committee work, oversight of financial reports and audits, and communications—all focused on fulfilling board governance duties rather than financial results or corporate actions. It falls under Corporate Governance Information rather than an Annual Report, Earnings Release, or Board Change Notice. Hence, the best match is Governance Information (CGR).
2026-04-16 Chinese
关于举行2025年度网上业绩说明会的公告
Regulatory Filings Classification · 0% confidence The document is an announcement by Shenzhen Opening Medical Technology Co. regarding the scheduling and logistics for an online “2025年度网上业绩说明会” (online performance explanation meeting) following the publication of its 2025 annual report. It does not contain the actual annual report or financial statements, nor is it the report publication notice itself about the 2025 annual report (which was already disclosed on 17 April). It is also not a proxy solicitation, call transcript, or investor slide deck. Therefore it falls into the general regulatory announcement fallback category.
2026-04-16 Chinese
第四届董事会第十五次会议决议公告
Regulatory Filings Classification · 1% confidence The document is the formal announcement of the resolutions passed at the company’s 4th Board of Directors’ 15th meeting, including approvals of the 2025 Annual Report, work reports, financial statements, profit distribution plan, internal control report, credit applications, cash management proposals, auditor reappointments, remuneration schemes, ESG report, and proposals to convene the 2025 shareholder meeting. It is not the report itself (e.g., Annual Report or ESG Report) but rather a regulatory board resolution announcement. It does not announce changes in board or management personnel (so not MANG), nor does it fit any other specific financial filing type. Therefore, it is best classified as a general regulatory filing (RNS).
2026-04-16 Chinese
2025年募集资金年度存放与使用情况鉴证报告
Audit Report / Information Classification · 1% confidence The document is a 13‐page assurance (“鉴证报告”) issued by a registered CPA firm together with a management “专项报告” detailing the annual deposit, management, and use of proceeds raised by the company. It is not a full annual or interim financial statement but is a standalone audit/assurance report on a specific regulatory matter. Therefore, it best fits the Audit Report / Information category (AR).
2026-04-16 Chinese
长城证券股份有限公司关于公司2025年度募集资金存放与使用情况的专项核查意见
Audit Report / Information Classification · 1% confidence The document is a standalone verification report prepared by the sponsor (长城证券) and an accounting firm on the storage and use of 2025 annual fundraising proceeds, complete with audit opinions, regulatory citations, and compliance checks. It is not a full annual report, earnings release, or simple announcement, but a specialized audit/review of fundraising usage. This aligns with the definition of an Audit Report / Information.
2026-04-16 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.